Feb. 24 at 1:57 PM
$INFU Q4 '25 Earnings Results & Recap
InfuSystem expects 2026 annual revenue to decrease by
$7.1M due to contract restructuring, but anticipates 6% to 8% growth for the unaffected business, with Adjusted EBITDA margin maintained in the mid to low 20% range.